Conversion of 6-substituted Tetrahydropterins to 7-isomers Via Phenylalanine Hydroxylase-generated Intermediates

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1991 Jan 15

PMID 1988938

Citations 19

Authors

M D Davis

S Kaufman

S Milstien

Affiliations

Soon will be listed here.

Abstract

A new variant form of hyperphenylalaninemia has recently been discovered in which the patients characteristically excrete 7-biopterin in their urines in addition to the natural 6-biopterin (Curtius, H. Ch., Kuster, T., Matasovic, A., Blau, N. & Dhondt, J.-L. (1988) Biochem. Biophys. Res. Commun. 153, 715-721). This isomer had not been found previously in humans, and although its origin was not established, preliminary evidence suggested that it might be produced from 6-biopterin. We have now found that 7-biopterin can be formed in vitro from (6R)-tetrahydrobiopterin during the hydroxylation of phenylalanine catalyzed by phenylalanine hydroxylase [L-phenylalanine, tetrahydrobiopterin:oxygen oxidoreductase (4-hydroxylating), EC 1.14.16.1]. The resulting 7-biopterin was unequivocally identified by the following criteria: preparative isolation and conversion to 7-hydroxymethylpterin following periodate oxidation and borohydride reduction, quantitative conversion to pterin-7-carboxylic acid after oxidation with permanganate, and liquid chromatography/thermospray mass spectrometry. Addition of 4a-carbinolamine dehydratase, an enzyme involved in the regeneration of tetrahydrobiopterin from the pterin carbinolamine intermediate (also called 4a-hydroxytetrahydrobiopterin) formed in the phenylalanine hydroxylase reaction, greatly decreased the amount of the 7-biopterin formed. This result implies that the in vitro formation of 7-biopterin occurs via the nonenzymatic rearrangement of the unstable substrate of the dehydratase, 4a-hydroxytetrahydrobiopterin, and suggests that this new variant of hyperphenylalaninemia may be caused by a lack of 4a-carbinolamine dehydratase activity. A mechanism for the rearrangement is proposed that predicts that other 6-substituted tetrahydropterin substrates of the aromatic amino acid hydroxylases could also give rise to rearranged products from an opening of the pyrazine ring of the corresponding 4a-hydroxytetrahydropterin intermediate.

Citing Articles

Insights into Molecular Structure of Pterins Suitable for Biomedical Applications.

Buglak A, Kapitonova M, Vechtomova Y, Telegina T Int J Mol Sci. 2022; 23(23).

PMID: 36499560 PMC: 9737128. DOI: 10.3390/ijms232315222.

Protein and pathway engineering for the biosynthesis of 5-hydroxytryptophan in .

Mora-Villalobos J, Zeng A Eng Life Sci. 2020; 17(8):892-899.

PMID: 32624837 PMC: 6999490. DOI: 10.1002/elsc.201700064.

Enhanced synthesis of 5-hydroxy-l-tryptophan through tetrahydropterin regeneration.

Hara R, Kino K AMB Express. 2013; 3(1):70.

PMID: 24321061 PMC: 4029321. DOI: 10.1186/2191-0855-3-70.

HPLC analysis of tetrahydrobiopterin and its pteridine derivatives using sequential electrochemical and fluorimetric detection: application to tetrahydrobiopterin autoxidation and chemical oxidation.

Biondi R, Ambrosio G, De Pascali F, Tritto I, Capodicasa E, Druhan L Arch Biochem Biophys. 2012; 520(1):7-16.

PMID: 22286026 PMC: 3307828. DOI: 10.1016/j.abb.2012.01.010.

Tetrahydrobiopterin biosynthesis, regeneration and functions.

Thony B, Auerbach G, Blau N Biochem J. 2000; 347 Pt 1:1-16.

PMID: 10727395 PMC: 1220924.

References

Kaufman S . A protein that stimulates rat liver phenylalanine hydroxylase. J Biol Chem. 1970; 245(18):4751-9. View

Kaufman S, Fisher D . Purification and some physical properties of phenylalanine hydroxylase from rat liver. J Biol Chem. 1970; 245(18):4745-50. View

Huang C, Max E, Kaufman S . Purification and characterization of phenylalanine hydroxylase-stimulating protein from rat liver. J Biol Chem. 1973; 248(12):4235-41. View

Huang C, Kaufman S . Studies on the mechanisms of action of phenylalanine hydroxylase and its protein stimulator. I. Enzyme concentration dependence of the specific activity of phenylalanine hydroxylase due to a nonenzymatic step. J Biol Chem. 1973; 248(12):4242-51. View

Smith I, Clayton B, Wolff O . Letter: A variant of phenylketonuria. Lancet. 1975; 1(7902):328-9. DOI: 10.1016/s0140-6736(75)91230-1. View

Kaufman S, Holtzman N, Milstien S, Butler L, Krumholz A . Phenylketonuria due to a deficiency of dihydropteridine reductase. N Engl J Med. 1975; 293(16):785-90. DOI: 10.1056/NEJM197510162931601. View

Kaufman S, Milstien S, Bartholome K . Letter: New forms of phenylketonuria. Lancet. 1975; 2(7937):708. DOI: 10.1016/s0140-6736(75)90806-5. View

Leeming R, Blair J, Rey F . Letter: Biopterin derivatives in atypical phenylketonuria. Lancet. 1976; 1(7950):99-100. DOI: 10.1016/s0140-6736(76)90204-x. View

Rey F, Rey J . Atypical phenylketonuria with normal dihydropteridine reductase activity. N Engl J Med. 1976; 295(20):1138-9. DOI: 10.1056/NEJM197611112952018. View

10.

Shiman R, Gray D, PATER A . A simple purification of phenylalanine hydroxylase by substrate-induced hydrophobic chromatography. J Biol Chem. 1979; 254(22):11300-6. View

11.

Bailey S, Ayling J . Cleavage of the 5-amino substituent of pyrimidine cofactors by phenylalanine hydroxylase. J Biol Chem. 1980; 255(16):7774-81. View

12.

Bailey S, Weintraub S, Hamilton S, Ayling J . Incorporation of molecular oxygen into pyrimidine cofactors by phenylalanine hydroxylase. J Biol Chem. 1982; 257(14):8253-60. View

13.

Niederwieser A, Blau N, Wang M, Joller P, Atares M . GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia. Eur J Pediatr. 1984; 141(4):208-14. DOI: 10.1007/BF00572762. View

14.

Niederwieser A, Leimbacher W, Curtius H, Ponzone A, Rey F, Leupold D . Atypical phenylketonuria with "dihydrobiopterin synthetase" deficiency: absence of phosphate-eliminating enzyme activity demonstrated in liver. Eur J Pediatr. 1985; 144(1):13-6. DOI: 10.1007/BF00491917. View

15.

Nichol C, Smith G, Duch D . Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin. Annu Rev Biochem. 1985; 54:729-64. DOI: 10.1146/annurev.bi.54.070185.003501. View

16.

Niederwieser A, Ponzone A, Curtius H . Differential diagnosis of tetrahydrobiopterin deficiency. J Inherit Metab Dis. 1985; 8 Suppl 1:34-8. DOI: 10.1007/BF01800657. View

17.

Kaufman S . Phenylalanine 4-monooxygenase from rat liver. Methods Enzymol. 1987; 142:3-17. DOI: 10.1016/s0076-6879(87)42003-x. View

18.

Dix T, Kuhn D, Benkovic S . Mechanism of oxygen activation by tyrosine hydroxylase. Biochemistry. 1987; 26(12):3354-61. DOI: 10.1021/bi00386a016. View

19.

Haavik J, Flatmark T . Isolation and characterization of tetrahydropterin oxidation products generated in the tyrosine 3-monooxygenase (tyrosine hydroxylase) reaction. Eur J Biochem. 1987; 168(1):21-6. DOI: 10.1111/j.1432-1033.1987.tb13381.x. View

20.

Dhondt J, GUIBAUD P, Rolland M, Dorche C, Andre S, Forzy G . Neonatal hyperphenylalaninaemia presumably caused by a new variant of biopterin synthetase deficiency. Eur J Pediatr. 1988; 147(2):153-7. DOI: 10.1007/BF00442213. View